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R&D, PATEN'tS, AND MARIET VALUE REVISITED:
IS THERE A SECOND(TECHNOLOGICAL OPPORTUNITY) FACTOR?
ABSTRACT
It is known that innovations in the market value of manufacturing
firms and their R&D expenditures are related (Pakes (1985) and Mairesse
and flu (1984)). This could be due to shifts in the demand for the
output of a particular firm, to shifts in the technological
opportunities available to the firm, or to both. In this paper we use
innovations in patenting activity as an additional piece of information
about technological shifts in order to attempt to identify the relative
importance of these two types of shocks. We build a simple two factor
model of innovations in sales, investment, R&D investment, patent
applications, and the rate of return to holding a share of the firm, and
estimate it using a time series-cross section of U.S. manufacturing
fins (340 firms from 1973 to 1980).
Except in the pharmaceutical industry, we find little evidence of a
second factor which can be clearly identified with technological
opportunity, although there is evidence of a long run growth factor
linking both types of investment, patenting activity, and the market
value of the firm. We then go on to demonstrate that this null result
could be caused by our use of patent counts as an indicator of the value
of the underlying patents: under reasonable assumptions on the value
distribution, the changes in patenting rates can account for only an
infinitesimal fraction of the changes in the stock market value of the
firm, and hence provide essentially no additional information to the
estimation procedure. However, the pharmaceutical industry is an
important exception to this: here we find that the technological factor
is almost as important as the short run demand factor in explaining
movements in the rate of return, although both factors together account
for less than five percent of the variance of this variable.
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1. Introduction
As part of our ongoing research on the economic content of patent
statistics we have been trying to ask the question, "Is there additional
information in patent numbers on the rate and output of inventive activity
above and beyond what is already contained in R&D expenditures data?" Can
one use such data to distinguish between "demand side" and technological
"opportunity" factors as they affect the rate of inventive activity? In this
paper we use information on additional variables, especially physical
investment and the stock market rate of return, to help us disentangle the
effects of such factors, We do it first in two different ways: once in the
framework of an unobservable two-factors model and then in a "causality
testing" type of analysis. When both approaches turn out not to be sensitive
enough to yield unequivocal information on the presence of such distinct
"factors", we turn to an analysis of the potential information content of
patent count statistics and show that, in view of the larger variance in
1patent values, this "failure" of patent numbers to be very informative
is not all that surprising. Nevertheless, the analysis of the relationship
between patent numbers andpatentvalues turnsoutto be quite interesting on
its ownmeritsand indicates some new avenues for additional research on this
range of questions.
Earlier work (Griliches 1981, Ben-Zion 1984, Mairesse-Siu 1984, and
Pakes 1985) has shown that fluctuationsinmarket value and R&Darerelated.
It is not clear however, whether these fluctuations arise largely on the
demand side, as Schmookler (1966) has argued, or represent shifts in
technological opportunity (cf. Rosenberg, 1974). Most likely both forces
are involved but it would be interesting if one could separate them and
provide some indication of their relative importance.
It is not obvious whether one can separate "demand" from "supply"
factors in this area, even conceptually. Our definition of "demand" factors
relates to macro shifts in aggregate demand,population,exchange rates, and
relative factor prices which make inventive activity more (or less)
profitable at a given level of scientific information, a fixed "innovation
possibilities frontier." We would identify changes in technological
"opportunity" as those scientific and technological breakthroughs which make
additional innovation more profitable or less costly at a fixed aggregate or
industry level demand. These distinctions are far from sharp, especially
given our inability to measure the contributions of science and technology
directly. Moreover, what is a technological opportunity in one industry may
spillover as a derived demand effect to another. Nevertheless, there is
something distinct in these factors, in their sources of change and
dynamics, which motivates our pursuit of this topic. We were led to it, in
particular, by our hope that the availability of detailed data onpatenting
would be helpful distinguishing between them.
2Patent data could help here if one were willing to assume that
independent, "unanticipated" shifts in the level of patenting by firms,
represent shifts in technological opportunities and not responses to current
changes in economic conditions (demand forces). That is. the identifying
assumption we will make is that the economy impinges on the level of
patenting only through the level of R&D expenditures (and slowly changing
trends) and that the "news" component in the patent statistics is either
error (random fluctuation) or a reflection of technological "news", giving
information that a particular line of research has turned out to be more
(or less) fruitful or easier (harder) than expected when the decision to
invest in it was made originally. That is, what we are hoping to identify
here are changes in technological opportunity as reflected in "abnormal,"
"unexpected," bursts (or declines) in the number of patents applied for.2
Several implications of this formulation are immediate. If patent
statistics contain additional information about shifts in technological
opportunities, then they should be correlated with current changes in market
value above and beyond their current relationship with R&D and they should
affect R&D levels in the future, even in the presence of the change in
market value variable since the latter variable is measured with much error.
Patents should "cause" R&D in the sense of Cranger (1969) ,atopic which we
shall explore in the third section of this paper.
The available evidence on this point is not too encouraging: While
Griliches (1981) found a significant independent effect of patents on the
market values of fins, above and beyond their R&D expenditures, Fakes
2. This and the following paragraph restate the formulation of the problem as
given by Fakes (1985).
3(1985), who studied this question bcsed on a slightly different two-factor
formulation, did not detect a significant influence of lagged patents on R&D
in the presence of lagged R&D and the stock market rate of return variables,
Nor did Hall, Griliches and Housman (1986) find future R&D affecting current
patenting as the "causality" argument might have implied.
Since the first two studies were based on relatively small samples
(about 100 fins) and since the Hall, Griliches and Hausman paper did not
investigate the relationship of market value to the technological
opportunity factor, it seems worthwhile to examine it a bit further, using a
slightly more general model, and a longer and more updated data set.
2. R&D, Patents, and Market Value in a Two Factors Model
The model we will consider is very simple: we look at five variables
which describe the current levels of the firm's output, stock market, and
investment performance: sales, capital expenditures, research and
development investment, patent applications, and the one period rate of
return to holding a share of the firm. All variables are defined as the
logarithm of their values (except for the stock market rate of return) and we
divide each observation into an 'anticipated" (predictable) and











where s is "real" (deflated) sales, i is tangible investment (buildings and
equipment), r is R&D expenditures, p is successful patent applications, and
4q is the annual stock market rate of return (defined as (V.V1+Div)/v1)
x is the anticipated or predictable (on the basis of past data) part of a
variable while x" is its "news" (innovation) component.
We make this division into "anticipated0 versus the "news" part,
because it is only the "news" part in the number of patents applied which we
wish to identify with changes in technological opportunity. Of course, one
could try to develop more explicit investment equations and expectation
formation equations, derive the "news" component explicity, and impose all
the available cross-equation constraints. Since our approach is
exploratory, we condition instead on all the available past data,
controlling thereby both for size differences and individual firm effects
and the past information on which such expectations would be formed. This
allows us to concentrate our modelling on the inovation components of these
variables, reducing thereby significantly the dimensionality of the
estimation problem.











where d is a "demand" shift factor which affects sales, investment, and
R&D concurrently, while t is a "technology" factor which connects
patents and R&D. Both factors affect also market value and are
5normalized to have a unit impact on it. The c's are specificerrors or
disturbances and are assumed to be uncorrelated with each other andwith
d and t.3 (I.e., it is assumed that the twoparticularfactors are
adequate to account for the intercorrelation structure in the S x S
matrix.) The major identifying assumptions are that "t" does notenter
the s and i equations (in the same year) and that "d" doesnot enter the
p equation1 except possibly via r
If the innovations in r are allowed to affect p directly, via ther
*
term, the reduced form equation for p is
— +
(iq1+q2)t + 7C3 + £4
and the resulting variance-covariance matrix of forecasterrors (the x*s)





where d2 —Var(d), t2 —Var(t) and —Var
(ck).
3. For the purposes of estimation,we assume that the distribution of d, t,
and the C's is stationary over time, to allowus to pool the estimates.
Allowing for changing variances and covariances wouldyield slightly
different standard errors, but the pooled estimatesare consistent even
in this case.
6That this model is identified canbeseen by trying to solve this
system recursively. The first row yields estimates of l' 2' and 'y.
The second row, given an estimate of ft1, yields an estimate of d2 (and
another estimate of 2• Having an estimate of d2 allows one also to solve
for and subsequently for and o. Given estimates of
and 42 yields, in row 3, estimates of q1t2 and in row 4, ,2t2. Multiplying
the main diagonal term of row 3 by -y and subtracting it from the first off-
diagonal term yields an estimate of 12t2 and hence also estimates 'l' 12.
and t2 and the rest of the parameters.
Given our assumptions, this is an overidentified model which can be
estimated in two passes. First run a seemingly unrelated regression system
of x on all the variables assumed to be in the "information" set and produce
the variance-covariance matrix of the residuals ("innovations"). Then f it
the model to the estimated residual covariances matrix using a maximum
likelihood program such as MOMENTS or LISREL (see the references).
Justification for proceeding in two stages can be found in MaCurdy (1981).
3. Basic Results
In this section we present the results of such computations. The
sample we used starts out with the NBER R&D data base (Cummins et al
1985), which is based on firms that were in existence in 1976 and had
good data for at least three years around that period. We selected only
firms which had continuous data on the variables of interest for some
period within 1970 to 1980. To minimize the measurement problems
associated with the discreteness of the patent variable at low values,
the particular sample used here was limited to those firms which
averaged more than three successful patent applications per year during
7the period over which we observed them.4 We also required that the
fin's fiscal year end sometime between October 31 and February 28,
since our patent data are available only on a calendar year basis. These
restrictions brought us down to about 340 firms per year (for up to
eight years after allowing for lags) and a total number of firm-year
observations —2377.
A
Thedefinition of x includes two lags of sales, investment,
employment, the firm-specific sales deflator, R&D, and q, three lags of
patents, and eight year dummies (reflecting common unanticipated macro
events). The resulting variance-covariance matrix of residuals and the
associated correlation matrix is shown in Table I. Before we look at it, it
is worth noting that as expected, in the forecast equations not shown here,
very little of the stock market rate of return is explainable by past
4. This still leaves us with some observations in individual years for some
firms where the number of patent applications is zero. In order to make
use of these observations after the log transformation, we set the
number of patents in such years arbitrarily to one third.
S. The main points to be made do not appear to be sensitive to the rather
drastic selection. Earlier we had used a somewhat tighter patents
requirement of at least six patents per year. Results are also similar
when the model is run on a larger sample based on an average of 600+
firms.
6. On theoretical grounds, we have in fact excluded all variables except
the year dummies from the prediction equation for q in the results
presented here. Except for possible measurement or timing problems due
to the non-coincidence of the fiscal year and calendar year, the current
stock market rate of return should not be predictable on the basis of
the prior year variables. This is confirmed in the data. Although the
existence of risk premia for the stocks of individual fins would
theoretically introduce some systematic variation in q, we found that
including two lags of q in the q equation reduced the variance by only
one tenth of one percent, and had no visible effect on the covariances.
8and that the tags of the stock marketrate of returnaresignificant
predictors ofboth physical investment and R&D. As we have previously
observed in these data (Hall, Criliches, and Hausman 1986 and Hall 1986),
both employment and R&Darehighly persistent with a coefficient on the
first own lag of above 0.9, while sales, investment, and patents are less
so.
Table 1 already gives thebadnews.Thecorrelation betweenthe p and
qresiduals is .007, implying that there is little room for a separate "t"
factor, or at least one whose identification depends on its "loading" on
both the q and the patents variable. The same conclusion is reached if one
uses the formulae in (3) and the data in Table 1 to try to compute the
various coefficients. A direct computation yields either negative or close
to zero values for var(t). In Columns 1, 2 and 3 of Table 2 we present
maximum likelihood estimates of the parameters of a one factor model (for
comparison purposes) and two versions of the two factor model (with and
without r* in the p* equation). To facilitate comparison with the
conventional factor model, we have renormalized the factors so. their
variance is unity, and d2 and t2 are now equal to the square of the factor
loadings on q. Both models yield a very small negative variance for the
second factor (see the estimate of t2) and almost no improvement in the fit.
Whydothe data yield these 'bad" results? After verifying our
data and sample, we considered the possibility that the appropriate
structural relationship to be Looking for is between lagged q and
contemporaneous sales, investment, R&D, and patents as in Fakes 1985).
Our q is measured between the ends of the previous and current year, so
this version emphasizes the role of q as a price influencing investment
decisions, while contaminating the news component of the variables with
some information that was available during the previous year. While
9we found that covariances were generally higher using lagged q in place
of contemporaneous q (and dropping it from the information set of
predetermined variables), the results for the twofactormodel were
worse, if anything: the second factor now has a distinctly negative
variance.
Although we focus on patents as an indicator of technological success,
the reason for our negative result lies partly in the R&D variable itself.
If we assume that one factor Links sales, investment, and R&D, then there is
clear prediction for the covariance of r and q which is based on the
relationship between sales, investment, and q. In the cases of both
contemporaneous and lagged q, the difference between the observed covariance
between r and q and the covariance due to d2 is insignificantly different
from zero or negative, leaving little room the technological factor.
Either is extremely small, or t2 is negligible. Only by allowing r to
enter the p equation directly can we justify the fairly large covariance
between r and p. and this leaves us with only twoverysmall covariances
between r and q and p and q with which to estimate t2.
It was a maintained assumption of our model that the technological
opportunity factor is only "news" for R&D,patents,and q. In arteffortto
explore further why our firmdatafail to reveal such a factor, we perform
in Table 2 a conventional factor analysis in order to test for the esistence
of a second factor of any kind. It turnsoutthat the data will not support
two factors with a complete set of loadings for all variables, since we have
a so-called "Heywood" case, where the off-diagonal covariances imply
negative idiosyncratic variances, but there is a two factor model with zero
restrictions which will fit the observed data perfectly (x2(2)—0.07): this
model is shown in Column 4 of table 2 and it differs from our original model
10only in that investment as well as R&D, patents, and q is allowed to load on
the second factor. While we cannot label this factor as pure
technological opportunity, because it may also reflect longer run demand
forces it is still an interesting finding in and of itself. However, the
contribution of this second factor to the variance of q is infinitesimal,on
the order of .02 percent, and its loading on p is not particularly
significant either.
¶Je have also estimated some of these models on nine fairly coarse
industry groupings (see Table 4 for a listing of them) and found that a one
factor model was sufficient in all but. three of them: Petroleum-Rubber,
Metals-Stone-clay-class, and Drugs. Only in drugs was the second factor
model sensible, in the sense that the variance estimates and the loadingson
p were all positive. These estimates are shown in Table 2a. The
coefficients for this industry (column 2 of Table 2a) imply that d2accounts
for 2.3 percent of the variance in the rate of return and t2accountsfor
1.5 percent. Thus in this industry, the patent-linked technological factor
is almost as important as the shortrun demand factor; this finding is
consistent with other evidence on the importance of patents in the
pharmaceutical industry, though again the statistical significance of this
finding (the factor loading on the patents variable) is not particularily
impressive.
Finally, the interesting finding in the preliminary regressions,
which create the "news" (unforecastable), components of these variables,
is the strength of the employment variable. In Table 3 we show the
first differenced (growth rate) version of these preliminary
regressions, which are somewhat easier to interpret than the level
11regressions.7 Changes in employment are as good or better than
changes in deflated sales in explaining changes in investment and R&D.
The most significant variables in the sales equation are the lagged
stock market rate of return and lagged employment growth. Neither
lagged investment, lagged R&D, or lagged patents are significant
although patents lagged twice are marginally so.
In the investment change equation the main important variables are
the lagged stock market rate of return, the lagged employment change,
and the lagged investment change (negatively). Lagged sales change is
insignificantin the presence of the lagged employment change, and its
coefficient is negative. Neitherlagged R&Dor lagged patent changes are
significantin the investment equation. In the R&D change equation, the
significant variables are the lagged employment change (.13(.OS)],
lagged stock market rats of return [.07(.Ol)], lagged sales change
[.l9(.04)], and the lagged R&D change (-O.07(.02fl. In the patent
equation1 besides lagged patent change [-O.46(.02)J, only lagged R&D
[.14(.06)) and lagged employment (.29(.12)] are significant. It appears
chat the employment change contains more information about the
"permanent" changes in the firm's fortunes than most of the other
variables. This last finding is consistent with Hall's (1986) finding
that there is almost no transitory measurement error in the employment
7. Except for the q variables, which we do not difference, the growth rate
regressions will be identical to level regressions with the first lag
coefficient constrained to be unity. Since this coefficient was near
unity except for patents, and the coefficients of the other lags tended
to be equal and opposite in sign, it is somewhat more parsimonious to
look at the regression in first differenced form.
12variable.
4. The Time Series Relationship of R&D, Patents, and Market Value
Another way of testing for the presence of a second, patents
connected factor is to return to the Pakes (1985) model and retest some
of his hypotheses on our larger and more recent data set.
In his model, there is one set of news that is associated with
contemporenous movements in q. r, and p which induces also subsequent moves
in r and p. In particular, his conclusion that the •news" works almost
entirely via R&D and hence a one factor model is adequate, is based on the
non-significance of lagged patents in the R&D equation, in the presence of
lagged R&D and the stock market rate of return variables. Another
implication of the two factor hypothesis is that current q should also
appear in the patent equation, reflecting the technological news not fully
recoverable from current R&D (due to superimposition of other sources of
variation).
Table 4 summarizes various tests of this sort performed
separately for different industrial groupings and for the sample as a
whole. A log R&D equation is computed containing three lagged values of
R&D, three lagged values of patents, and the current and three lagged
values of the stock market rate of return. The first test asks whether
lagged values of q, beyond the first lag (which was the measure used by
Pakes) enter this equation. The second test includes the first lagged
q, which enters significantly in more than half theindustries. The
third test asks whether all the lagged patent variables could be deleted
from this equation while the fourth test asks whether one lagged value
of R&D is enough. The regressions are based on the same unbalanced
panel of firms as Table I, with slightly fewer observations due tothe
13additional. lags of r, p, and q.
turning to the third test first, the one of most interest to us,
lagged patents are barely significant in the overall sample and the
relevant coefficient is-not economically significant (for Log p2 it is
O.02(.Ol)). Lagged patents are significant in the Chemicals and
Electrical groupings; in both cases it is the second lag rather than the
first. In Drugs, where we might have expected to see the strongest
effect, because of the economic importance of patents in that industry,
all the coefficients are insignificant, as is their sum. This may not
be unreasonable per se.It says that a burst of patents does not lead
to a permanent increase in R&D above and beyond the level which was
forecastable from lagged r and q, reflecting a transient rather than
permanent technological opportunity.
Lagged q (the stock market rate of return) is a significant
determinant of R&D overall and for most of the industrial grouping
separately. two and three year lagged values of q are also significant
overall but only for the non-electrical machinery grouping separately,
implying that there may be serious costs in adjusting R&D rapidly to
current events. Overall, lagged q, the original Fakes formulation, is a
somewhat stronger variable than current q (about twice as large on
average with substantial inter-industry variation), implying again that
it may take some time to adjust R&D to the market and technological news
that are implicit in q.
Table 5 lists similar results for the patent equation where the
first test asks whether lagged q's enter the equation above and beyond
current and lagged R&D levels; the second test asks whether adding current q
contributes to the explanation of the variability in patent applications;
14while the last test asks whether there is a significant lag in the effectof
R&D on patent applications (it is a follow up on the question explored in
Hall, Criliches, and Hausman, 1986). At the pooled all-industries level
none of these effects seem important. Neither current or laggedq are
either individually or jointly significant and lagged R&D valuesare only
barely so. q is marginally significant only for the firms in Primary
Metals, Stone, Clay, and Class while lagged R&D is of some importance in the
Petroleum, Drugs and Metals groupings.
Table 6 gives the estimated coefficients for both R&D andpatents
equations for the overall pooled sample, indicating the type of result
yielded by this approach. Note that lagged R&D expenditures are not
statistically significant in the patent equation either. The stock market
rate of return does explain movements in R&D but not in patents and R&D is
close to a random walk while there is much more evidence of a persistence in
a firm's propensity to patent. These findings are effectively the same as
in Pakes (1985). A bigger sample and more variables have notreally
increased our ability distinguish between the various hypotheses about the
underlying sources of these fluctuations.
5. Patent Counts and Patent Values.
Whyarethese results so poor and fragile? The answer to this
question lies in the noisiness of patents as an indicator of the value
of inventive output. Beginning with Schmookler's critics and possibly
even earlier the use of patent statistics as an invention indicator has
been questioned on many grounds. The problems cited by critics of the
patent count methodology are twofold: first, not all useful innovations
are patented; in fact in some industries very few may be. Second, the
distribution.of the value of individual patents is extremely skewed
15toward low values. There is informal evidence on this point (see
Freeman (1982) and the references there) and there are recent estimates
by Schankerman and Pakes (1986) and Pakes (1986) of the distribution of
the value of patent rights in several European countries. There are
also calculations by Crabowski and Vernon (1983) of the distribution of
the value of New Chemical Entities for pharmaceutical companies, which
probably corresponds to the upper tail of the patent value distribution.
This empirical evidence, although somewhat sparse and imprecise,
confirms what most of those knowledgable in the field would say: a few
patents are worth a great deal in present value terms while most are
(nearly) worthless.
From the point of view of the present attempt to identify a second,
more technological opportunity related factor, this skewness in the
patent value distribution is bad news. In order to identify this second
factor, we need to measure the covariance between the increase in the
present value of the firm which is signalled by the new patents and q,
the stock market rate of return; the closest we can come to measuring
this quantity is to measure the covariance between current patent counts
and q. and the quality of this measurement is dependent on the quality
of the link between counts and values.
It is possible to derive the quantitative implications of such a skewed
distribution of values for the quality of the patent count indicator by
combining what we know about patent counts in both the time series and cross
section dimension with estimates of the distribution of their values.
Following Criliches (1981), assume that at any point in time a firm
possesses a stock of knowledge, K, which was produced by the past stream of
R&D expenditures. Each year. there are surprises in the additions to this
stock of knowledge generated by current and past R&D. We assume that the
16number of patent applications in &year,nt. is an indicator of the size of
the surprise associated with new inventions that occurred during this
period.8 In addition, there are also surprise revaluations of past
"news", of the discoveries of previous years. We now proceed to estimate
the relative importance of patents as a component of the variance in the
firm's rate of return.
Let us decompose the change in the value of the firm (net of its
expected dividend and investment policy) into three components:
where is the rate of return on stock holding, Vt is the total market-
value of the firm's assets, and three components w. andu are defined
to be orthogonal to each other. w corresponds to the change in the value
of a firm's R&D "position" (program) arising from the "news" associated with
current patent applications. reflects revaluations of previous
achievements associated with past patents (above and beyond their correlation
with current patents). u reflects all other sources of fluctuation in the
value of the firm, including also possibly the contribution of not patented
R&D. We shall first focus on w and the role of patent numbers as an
indicator of it. Next, we shall ask about the possible magnitude of the
variance of w (relative to the variance of qV). That is, how large could
the contribution of current patents be to the explanation of fluctuations
8. This is an oversimplification since the average patenting level of the
firm is predictable based on its history. However, given the level of
the noise in the value distribution, it is not unreasonable to begin
with this assumption and then correct the observed variance for the
predictability later in the computations. It will make very little
difference to the result.
17in market value, even if we had perfect measures of the values? Indirectly,
we shall be also asking how big is the haystack (the fluctuations in market
value) relative to the needle that we are searching for. Finally, we shall
sketch out a procedure which should allow us, in principle, to estimate the
variance of q, the contribution of the revaluations of past patenting.
In order to decompose the variance of the first component, we make the
following stochastic assumptions: 1) The number of patents applied for each
year is distributed as a Poisson random variable with a meanwhich is a
distributed lag of past R&D expenditures (see Hausman, Mall, and Criliches
1985).2) yi, the underlying value of each patent to the firm is
distributed as a log normal random variable with a mean and variance which
will be derived from the earlier literature. With these assumptions, the
total value of the patent applications of a firm in any one year is
Wy
where p is Poisson and y is lognormal.
If p is Poisson and y is lognormal, the first two moments of w
(under independence) are
E(wl —E[py]—AE[y] where A —E(p]
V(w] —V(y) —AV(y] +[Ey32A
Note that in this model, and in Hausman, Hall. and Criliches, A is taken
as a function of R&D. Hence, given an R&D policy, A is a constant for
the firm. Since we shall be allowing for the contribution of R&D
changes separately, it is reasonable to make this computation holding
R&D constant. We are interested in the value of the news contained in
18the patent variable above and beyond what is already summarized in the
R&D variable. That is, we are looking for patents to measure the
"output" value of the R&D process above and beyond, and distinct from,
its "input".
The component of the variance of w which could be accounted for by
patent numbers corresponds to the last term
Var (n yJ —
andits relative size is given by
Var (n y] /Var (w] —l/(l+V(y)/(Ey]2)—l/(l+12)
where r is the coefficient of variation in the distribution of patent values.
Now we can turn to the literature for some order of magnitude estimates
of these various parameters and make a few illustrative calculations. For
this purpose we need estimates of Ey, the average increment to the value of
the firm associated with an "unanticipated" patent, and Var(y), the variance
in this value. It will become clear, shortly, that our conclusions are not
particularly sensitive to the precise value of such parameters and hence we
will not try to defend them in great detail.
Turning first to the mean value of patents we have estimates of the
value of the news associated with patents in the U.S. of between $200,000
(Griliches, 1981) and $800,000 (Pakes, 1985) per patent. There is also some
information on this point in our data: using the covariance matrix in Table
1, we can regress q on the news in patents to obtain an approximate estimate
of the rate of return to an increase in patenting. This produces an
estimate of $98,000 per unexpected patent at the geometric mean of our data
(with a very large standard error). The data for the drug industry, where
patents are more important, yield a larger and somewhat more precise
19estimate: an $821,000average increase in the value of the firm per
unexpected patent. This is in fact very similarto the Fakes (1985)
estimate which wasbased on a smaller sample of larger firmsand is
thereforemorecomparable to our drug firm subset.
If we take the upper range of these numbers, $800,000 per "unexpected"
patent, and use A— 13,the average (geometric) number of patents received
in our sample (per year. per fin), the expected contribution of the
variance in patent numbers to the average variance in market value is
13(•3)2 (mil$)2 —$8.3million squared. This is to be compared to
the average variance of qV in our sample. The variance of q is 0.133 which,
evaluated at the geometric average value of our finns ($276 million),
yields a variance of market value changes on the order of $10,000 million
squared. Comparing the two variances yields an estimate of the size of the
needle as less than one-tenth of one percent (.0008). And this number is
already based on the upper range of the available estimates!
The next task is to estimate the potential size of Var(w). the variance of pacer
values rather than its approximation by patent numbers. For this we need
an estimate of Var(y). which we shall try to borrow from Schankerman and
Fakes (19a6).9 If we take their numbers for Germany from their tabLe 4 and
project the distribution of present values of patent rights back to age
zero on the basis of the relationship between their estimates of this
9. Shankerman and Pakes obtain distributions ef the value of the patent right to the
/ sincetheir estimates are based on the decision to patent; while we are assuming
that the value of the underlying innovation to the firm is proportional to
the patent right value and highly correlated with it.
20distribution for age three and age five10 we get approximate estimates of
the mean and variance of the lognormal distribution (9.25 and 2.62
respectively, estimated from the inter-quartile range of this
distribution), which imply an arithmetic mean patent value of about $39,000
and a standard deviation of $139,000. Of course the average value of the
news in a patent for a U. S. manufacturing firm is undoubtedly higher both
due to the larger market and the higher value of corporate patents.
Multiplying through by 3, to adjust roughly for the relative size of the
two countries yields comparable U.S. "estimates" of $116,000 and $413,000
respectively.
Since we are looking for upper-bound estimates, we shall take from them
the implied estimate of 3.6 for the coefficient of variation in these
values. (Similar estimates in Pakes 1986 can be interpreted as implying a
coefficient of variation on the order of 3). Applied to our "upper" range
estimate of Ey —$0.8million, it implies a variance in y of (3.6 x $0.8
million)2 —$8.3million squared. The total variance of w is now
l3U2.88)2 +(.8)2)—$166million sq.
or a little over one percent of the total variance in market value. That is.
even if we had good estimates of patent values, they would account for very
little of the fluctuations in market value. Having numbers instead of
values only makes matters worse, reducing this fraction even further. The
10. The ratio of the arithmetic means in the two years is 1.32, which
suggests a depreciation rate of fifteen percent per year for the sample
of patents which survive until the fifth year (over 98 percent of all
patents granted).
21contribution of patent numbers to the variance in their values is only on
the order of .7 percent 11(1+3.6), and their contribution to the explanation
of the variance in the unexpected changes in the market values of individual
firms is even smaller, •an infinitesimal .0008.
For the drug industry, where the variance of market values is smaller
(Var q —0.06) and the average number of patents received is larger (23),
the news in patents could account for as much as 2 percent of the observed
variance in the market value of firms but patent numbers would pick up less
than a tenth of this still rather small fraction.
There are two major problems in using this procedure to estimate the
variance of the news in the economic value of patents held by the firm:
the first is that the distribution estimated by Schankerman and Fakes is a
distribution of the value of patent rights, which may be less than the true
economic value of the associated invention to the firm. Thus our estimate
may be an underestimate of the variance in the value of inventions. Using
the upper bound of the various estimates based on our stock market rate of
return data for the drug industry we have tried to correct for this
problem. The second problem probably goes in the other direction: some of
the change in the fin's patent value this year may not be news, and thus
may already be incorporated into the market value at the beginning of the
year. But allowing for some predictability of patent numbers would only
reduce such fractions further, multiplying them essentially by 1-ft2 of the
prediction equation. Because of these problems we try an alternative
approach in the next section.
6. Estimating Variance Components
An alternative approach to this question can be developed from an
explicit modelling of the components of variance in stock market value
22surprises as a function of current and past patenting and R&D activity. In
principle, this approach allows us also to estimate the contribution of
revisions in the value of past patents to current changes in market value.
Unfortunately, the estimates in this case are based essentially on fourth
moments of the data and are, therefore, rather imprecise.
The estimating equation, which is derived in greater detail in




is the squared annual change in the stock market
value of each firm, and x is the surprise component in current patent
applications
xit —- P)2
to be estimated using a patent forcasting equation described in Table Al.
Equation (3) partitions the variance in market value surprises into
three components: the contribution of the "News" in current patents --
thecontribution of the revaluations in the past and previously
anticipated patents -.Sa2p and the contribution of all other sources
of market value change--a. The major assumption made in deriving this
equation is that the various individual surprises and revaluacions are
independent of each other, the common components being captured by time and
2
also possibly firm dummies. The parameters to be estimated are ,the
square of the average patent value, o, o, c, c,
the variance of the surprises in the values of patents of different
vintages, and a set of dummies reflecting common macro events (the
Before we estimate this equation we need to confront the following
- 23problem: qV in our data ranges all the way from $7,000 to $12billion,
owing to the large size range of our fins. Since the majorityof firms
have changes in market value at the lover end of this range, the
dependent variable in equation (3) has a very skewed distribution.
Consequently we expect that it will have considerable size-related
heteroskedasticity. This will not bias the results if we have
exactly the correct model for (qft Vit)2. but it does tend to place more
weight on the extreme observations than we might like. If the true
model has some nonlinearity, for example, weighted least squares
estimates may differ substantially from unweighted ones.
We choose to mitigate this problem in this case by allowing each firm
to have its own average level of variance in annual stock market value
changes. That is, we write as
e—.it I.it
and we estimate ci. the fin specific variance of qV, along with the
other parameters of the equation. This introduces approximately 400
nuisance parameters into the regression, but, as is well known, the
estimates from a linear regression on panel data with fixed effects are
still consistent. After introducing these fin effects, we find that
the simple lagrange multiplier test for heteroskedasticity of the
residuals now has a value of 51. with 12 degrees of freedom, which is
significant but not greatly so.
11. In fact the TR2 from a regression of the residuals squared from this
regression on the independent variables is 131.2 with 12 degrees of
freedom.
24The results of estimating equation (3) are shown in Table 7. The F-
statistic for the industry effects in column 2 is F(19, 2468) —5.65and
that for the firm effects is column 4 is F(367, 2120) —3.18.Because we
believe that not allowing each firm to have its own variance may bias the
coefficient estimates (for example, if the general riskiness of the firm is
correlated with its patenting activity), we focus on the estimates in
columns 3 and 4. From these estimates, we hope to get an approximate
measure of js'1, the expected return to a patent application, and a2, r
—0,1 the variance in the revision of the value of a patent
application which is r years old. The estimates shown are not completely
2
sensible since they imply a negative value of ,f' ,althoughwith a fairly
large standard error. Thus, at best, the expected value of a patent
application is approximately zero using this methodology (remembering that
the variable in question, x, is imperfectly measured in any case). The
estimates of 2, on the other hand, imply that the news about patent
values is of roughly the same order in the first two years after a patent is
applied for, with substantial revisions in value taking place even after
three or more years (as is indicated by the large estimate for the P3
coefficient)
We are particularily interested in estimating the part of the
variance of the stock market return which is attributable to news about





Intable 7 we display this quantity, under the assumption thatfl—0.9.
It is quite large, on the order of $500 million squared.
It implies that the variance in the news about the value of patents
25(current and past) could account for over five percentof the total. variance
in market value surprises. This is not a negligable amount, giventhe high
market volatility from other sources.
It is also consistent with our previous. "back-of-the-envelope"
calculations of the potential contribution of the news value in current
patents, which we had estimated at $166 million squared.If we take the
last number in Table 7 ($538 mill. sq.) to be the variance associated with
an average stock of 52 (4 x 13) patents, each with an independentrevision
in its value, then the implied standard deviation of an individual patent
value revision is on the order of $3.2 million. Given our earlier
assumption of a coefficient of variation of 3.6 in patent values, this is
in turn fully consistent with the assumed $800,000 news value per new
patent in the previous section.
7. Concluding Comments
In this paper we tried first to use patent and market value data at the
firm level to distinguish between "demand pull" and "technological
opportunity" push forces affecting inventive activity. Two different ways
of looking at it, via an unobservable factors model and via time-series
causality testing, yielded interesting but statistically insignificant
results. The data were not strong enough to discriminate between the
various hypotheses.
We asked ourselves, then, perhaps belatedly, the question: can such
effects be estimated at all with the data at hand? What is the potential
information content of patent data, especially in the context of using
market value changes as the variable to be explained?
Two relatively simple conclusions emerged from this examination: (1)
If we are interested in estimating the impact of the value of inventive
26output using only patent counts as an indicator, we are, at best, likely to
capture only about six to ten percent of it, using such measures. (2)
Trying to do so in the context of market value change equations makes this
task almost impossible, primarily because of the stock market's very high
volatility. Our conclusions can be restated in terms of the following
orders of magnitude. Fluctuations in the market's evaluation of the patented
portion of firm's R&D program could account, perhaps, for about five percent
of the total variance in market value surprises, of which about one-fifth
might be attributable to the news associated with current patent
applications. But, using only the number of current patent applications
would account for less then 0.1 percent of the total variance, making tests
of any hypotheses associated with these effects rather difficult to perform.
Yet another way of making the same point is to note that the estimated
0.08 patent counts variance component translates itself into a required
sample size of 5000 for a t-ratio (significance level) of 2 (t —2—.0008N,
N —5000).We are not that far away from it in the aggregate regressions:
Our sample size is about 2500 and we would need "only" to double our sample
size to approach 'significance." But at the industry level the outlook is
not particularly optimistic. Only in the drug industry, where we estimate
that patent counts could account for about one percent of the variance n
market values, might a modest expansion in sample size be adequate.
We do develop an alternative approach, using a model of the variance in
market values, which allows us to estimate the variance component associated
with patent count fluctuations, but here too, because the approach relies on
fourth moments of the data for identification, larger samples and/or more
relevant variance in the independent variables may be a prerequisite for
further progress.
The major conclusion of this paper is that one should probably not be
27looking at data on stock market fluctuationsifoneis trying totest
detailedhypothesesabout the information content of patent statistics.
Because the variability of stock market values exceeds by anorder of
magnitude the variability associated withanyof the "reaP causes that one
might estimate, ourestimatesdo not tell us that the returns to inventive
activity are small or that the topic we have been pursuing is not
interesting, only that we have been looking for our particularneedle ina
verylarge haystack and should not be really surprised when we areturned
back empty-handed.
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s i r p q
s .014177 .016585 .007351 .00017 .008257
1 .186597 .014282 .003742 .012137




s 1.0 .322 .302 .0028 .190
i .162 .017 .077
r 1.0 .071 .074
p 1.0 .007
q 1.0
Residual variances, covariances and correlations from regressions
containing the same variables lagged once and twice, lagged values of






q -stockmarket rate of return.
All variables are in logarithms of original values except for q.
29Table 2
Estimates of Factor Models
Number of Observations —2377
One Factor Model Two Factor Models
r in peq.
Loadings on Factor 1
$ .O96(.OOS) .095(.014) .095(.O14) .1O8(.O17) .O95(.0ll)
I .173(.Ol2) .174(.02O) .174(.O2O) .154(.O25) .156(.027)
.077(.O06) .O78(.O09) .078(.0O9) .068(.O11) .102(.O34)
p .011(.013)
- - - .041(.033)
q .084(.O09) .085(.O1O) .085(.OlO) .076(.O14) .O70(.014)
.0O70U0016) .0073(.OO17) .OOJ3(.OO17) .0O58(.0027) .0048(0020)
Loadingson Factor 2
- - - - .051(.041)
I - - - .043(.034) .035(.O43)
- ** ** .088(.065) -.O46(.056)
p - ** ** .085(.064) .O73(.063)
*
q - ** ** .OOS(.023) .032
- - .00005(.0009)-.000003(.00006).00002(.00022) .00102*
IdiosyncraticVariances
s .0O49(.O010) .0050(.001O) .0050(0010) .0025(.0036) .0025(0036)
1. .1567(.0055) .1565(.0056) .l565(.0O56) .1611(0077) .1611(.0077)
r .0358(.0012) .0374(.0033) .0385(.0018) .0292(.0108) .0292(.0109)
p .2699(0078).4384(2.78) .3179(2.17) .2629(.0131) .2630(.0130)
q .126O(.0038).1252(.004O) .1257(.0038) .1271(.0040) .1271U0040)
log L-1785.4 -1782.5 -1782.5 1778.2 1778.2
x2 14.4 8.6 8.6 0.07 0.05
DF 5 3 2 2 1
30Table 2*
Estimates of the Factor Models
PharmaceuticalIndustry




s .061(.007) .066(.032) .069(.013)
i .133(.024) .127(.060) .123(.030)
r .079(.Oll) .077(.034) .074(.015)
p .O1l(.037) -
q .O43(.019) .038(.0l7) .036(.019)
d2fl* .0O18(.00l6) .0014(.O0l3).00l3(.O0l4)
Loadings on Factor 2
S - -
- - .024(.O4O)
r - .0458(.033) .050(.037)
p - .323(.392) .295(.216)
q - .O29(.023) .033(.O27)
- .0009(.OOI4) .OOll(.0O18)
Idiosyncratic Variances
s .0024(.0008) .0O18(.0008) .0O14(.O0l1)
i .0887(.0089) .09O2(.0080) .09O9(.0O93)
r .O085(.O015) .0O72(.0025) .0O72(.O026)
p .2411(.0220) .1368(.13O2).1539(.1270)
q .O582(.0054) .0579(.0O49).O578(.0054)
log L243.5 254.1 254.3
x2 24.1 3.0 2.6
DF 5 , 3 2
31Notes to Table 2 and Table 2a
*This parameter was fixed at this value since the model with two free
factors was not estimable in this data (see the text).
Because the estimate of the variance of the second factor t2 is
negative these factor loadings are not computable (they are imaginary).
Since we estimated the fa9or modls with the variance of the factors
normalized to be unity, the t and d parameters are just the square of


































These are based on the same dataset as the first stage regressions for
Table 1. The variables e and d are employment and the firm specific
sales deflator respectively. .i,and r are deflated variables (see


























































TheR&D Equation: Summaryoftest Statistics
Number of PLns —340
1973- 19 80
P Statistics for the Hypothesis of Zero Coefficients
test 1 test 2 test 3 Test 4
All p r2r3r4
Sample
Groupings F(Prot F(Prob) F(Prob) F(Prob)
1) Food 6 278 .18 .20 44j* .30
Chemicals .998 (.83) (.89) (.01) (.74)
2) Petroleum & 190 1.63 2.54 1.42 .76
Rubber .998 (.20) (.06) (.24) (.47)
3) Metals, Stone 173 1.40 2.41 .90 4.96*
Clay Glass .993 (.2S) (.07) (.4S) (.01)
4) Drugs 228 .24 1.12 1.89 6.14*
.999 (.79) (.34) (.13) (.00)
5) Machinery, 460 4.65* 4.00* .83 2.14
Engines, & .984 (.01) (.01) (.49) (.12)
Fabric. Metals
6) Computers & Sci. 370 .91 498 1.29 10.43*
Instruments .991 (.40) (.00) (.27) (.00)
7) Elec. Mach. & 290 .22 1.67 3.23* 1.26
ElectronLcs .996 (.80) (.17) (.03) (.29)
8) Motor Vehicles181 1.00 9* 1.33 2.32
S Aircraft .997 (.37) (.02) (.27) (.10)
9) Other 157 .32 3.88* 1.82 1.81
.989 (.73) (.01) (.15) (.17)
Total Sample 2154 9.53' 24.73* 555* 1.60
.995 (.000) (.000) (.05) (.20)
See the following page for notes to the table.
34Notes to Table 4:
Theestimatedequationis of the form
r—yeardummies, q,q11q21q3, r11r2,r_3, p1'p2.p3.
where all the lower case variables except q are logarithms of the
original variables.
The sample is an unbalanced panel of firms with good R&D and market
value data, a fiscal year end between October and February, and an
average number of patents over the whole period of at least three per
year. The period covered is 1973-80, for between 160 to 340 firms. In
a few cases where the number of patents was zero in a particular year, p
was set to .33.
+N.risthe number of fin-year observations; there are up to eight years
per firm.
*statistically significant rejection of the null hypothesis. The
numbers in parenthesis are the "probability levels" corresponding to
the particular test statistics.
35Table 5
Patent Equation: Suiuary of Test Statistics
F Statistics for the Hypothesis of Zero Coefficients
Test 1 Test 2 Test 3
lagq Allq lagr
sample
Groupings F(prob) F(prob) F(prob)
1) Food & 278 .97 .87 .70
Chemicals .990 (.41) (.48) (.56)
2) Petroleum & 190 1.76 1.34 394*
Rubber .989 (.16) (.26) (.01)
3) Metals, Stone 173 .90 2.46* 4.65*
& Class .976 (.45) (.05) (.00)
4) Drugs 228 .98 .89 533*
.981 (.41) (.47) (.00)
5) Machinery, 460 1.90 1.42 1.74
Zngines, & .952 (.13) (.23) (.16)
Fabric. Metals
6) Computers & 217 1.52 1.21 1.65
Sci. Inst. .984 (.21) (.31) (.18)
7) Elec. Mach. & 270 2.18 2.25 .66
Electronics .964 (.09) (.06) (.58)
8) Motor Vehicles 181 .44 .33 .15
& Aircraft .981 (.73) (.86) (.93)
9) Other 157 1.02 .78 1.44
.960 (.39) (.54) (.23)
Total Sample 2154 .51 .61 385*
.974 (.68) (.65) (.01)
Notes:
The equation estimated is of the form:
p —year dummies, q,q1,q2,q3, r,r1,r2,r3, p1,p21p3.
See the notes to Table 2 for additional detail.
36Table 6
EstimatedLogR&D andLogPatentsEquations
for U.S. Manufacturing Firms
1973-1980
Dependent Variable
Log R&D Log Patents










Log R&D - - .212(.O56)
Log R&D_1 .961(.O21) .053(.O77)
Log R&D2 .018(.028) -.143(.073)
Log R&D3 .Oil(.020) -.021(.052)
Log P1 .012(.009) .489(.022)
Log '-2 .024(.009) .250(.024)
Log P3 -.026(.009) .139(.022)
StandardError .204 .528
Notes:
This sample is the same as that in Tables 2 and 3. It is "unbalanced," in
the sense that the number of available data points varies from year to
year. Both equations contain year dummies.
Standard errors are in parentheses.
37Table 1




Model (1) (3) (4)
-.012 (.006) -.008 (.006) -.019 (.008) -.015 (.008)





-f 1.55 (.21) 1.16 (.22) 2.58 (.29)
Industrydummiesno yes no no
Firmdummies no no yes yes
Estimated Vt .89 (.30) .36 (.30) 5.63 (.25) 5.38 (.25)
Estimated p - - -
Allequations contain year dummies.
The dependent variable is the change in market value of the firmduring
the year. squared. The coefficients ofpatents and of the dependent
variable are in units of a hundred million dollars squared (1016 $2)
*
Thisestimate is calculated using equation (5) with fi—0.9.
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40Appendix A
Estimating the Distribution of the Value of Nan inPatenting
In this appendix we present the theoretical justificationfor the
regression equation (3) which allows us to perform a variance
decomposition of the variance in the firm's one period rate ofreturn
into the fraction due to news in the value of patents (boththose taken
out this year and in prior years) and all other news.
Let there be some underlying measure space which sufficesto define
the joint distribution of the sequence of net returns to allpossthle
patents and the number of patents applied for, say (0, 5, Q). The
sequence1 (... 1÷l 3t÷2' ...S 5),is a sequence of increasing
sub a-fields ("information sets"). We assume that allmoments needed in
the subsequent presentation are finite. Any otherassumptions are
stated explicitly where necessary.
For the generic patent taken out in year q, let
(Al) Vqo — 0 S ftS1
where (rq+j) are the sequence of net returns associated with thepatent,
and define
(A2) vqa —fttqj
so that (v) is the sequence of discounted values of net returns q,a












the conditional expectation of x where we condition on S, the
information available at time t. Note that for a > 0
0 ifr<a
(A4) E[q 15 1 —
q,aq+t ifr￿a
q,a
That is, the innovation in the returns to a patent taken out in year q
which occur in year q+a are in the information set for years q+a and
later. We define the initial expected value of the patent as
(A5)
E[Vqo '3q-11 —5[1qQ'3q-11 —
{lqj)
is a sequence of mutually uncorrelaced random variables by
construction.
With these preliminaries out of the way, we can write down the
value of the patent stocks held by a firm and partition this value into
the predictable (measurable3q•l and unpredictable part. We expect
only the latter part to be reflected in the current stock market rate of
return (at year q). Let be the expected discounted value of net





p(q) denotes the number of successful patent applications taken out in
year q and Viqt..q is the value of the ith patent taken out in year
q
remaining in year t. Note that p(q) is known with certainty atany t t
q, but not at t —s
-1(that is, () is measurable w.r.t.
Under the assumption that the stock market value of the firm in
year t-l incorporates all the information in 5ql' the theoretical model
for the relationship between news in the value of patents and the stock
market value of the firm gives
(Al) —- +
—(Wo







'i,t-l,l '1i,t-2,2 + + Ct
To simplify the analysis we assume:
43Al: The distribution of (Ps. v1o. v201 v30 ..)conditional
on 3tl factors into the distribution of Pt conditional on and that
of (vio v20 v30• ...). Moreover(vito. v20
consist of a sequence of exchangeable random variables.
Assumption Al Implies that each member of the sequence {v1o) has
a common mean which is independent of the number of patents applied for
(there is no cx ante relationship between the quantity of patents and
their expected values). Given assumption Al, we have that
p(t)
(A8) E1 vioti ￿
P(t))]
—is
where is" is defined above and —Et1p(t).Hence
p(t) p(t)




where — -s.Substituting into equation (0) we
have
p(t) p(t-l
V p VS'— v-. (AlO) — - +Li,t,oL.'7i,t-l,i.
+'.+Ct
i—i i—i
Thus, we have decomposed the one period rate of return to owning
the firm into a part consisting of the surprise due to the number of
patent applications this year, a part consisting of the news in the
value of patents applied for thisyear, parts which are news about the
value of old patents held by the firm which is learned thisyear, and,
finally, an residual which contains all other news which affects the
value of the firm, but is uncorre].ated with currentor past patents.
44The simplest way to see the variance relationships is toassume
p(q)
£2:Thedouble sequence {nit.qJ isa sequence
i—l,q—O





I. rt rtl. .
— V(p
-P)+ Pt + -i,i nt-i ÷ ...+
2
2
This is our regression function. Parameters are a,
°l "independent" variables are (p-pP)'Pt.
and so forth.
In order to actually estimate the regression, we need to know
pP)2 the squared surprise inpatent applications for the ith firm
in year t conditional on Since this quantity is unobservable, we
estimate it by regressing the observed on lagged p, lagged r, time
dummies, and industry dummies (to control for the differing propensity
to patent in different industries). We then form a predicted number of
patents in each year for each firm p using the estimated
regression coefficients and the observed p and r of the firm. The
estimated log patents equation which we use is shown in Table Al. We
found that the I it was improved substantially when we included squared
lagged patents and squared lagged R&D (1(2,2575) —63.2).Although the
industry dummies are not very significant (1(19,2555) —2.0),we
included them because some industries patent substantially less than
45others andnotcontrolling for this would overestimate the variance of
thenews in the patent counts. Thus the equation we used for predicting
in the following computation is based on column (3) of Table Al.
2 2
Now let y —(qV),and —(Pt
-p)
.Rewriting
equation(All), we have (under Al and A2)
(A12) y — +x + p(t-r)÷
where c is the "error" in the equation and
IXi:tPt Pt_it..]— 0
For the empirical work reported in the paper, we assume in addition
AS: — , v—
A3merely specifies that the distribution from which patent values are
drawn does not change during our time period, which is about eight to
ten years. Using this assumption, the regression equation becomes
(A13)y + p1'x+ 2 Pt.? +
which gives us time-homogeneous coefficients (except the constant term).
The subscript i indexes firms and t indexes years. When we estimate
equation (A13), we include three lagged values of patent application
counts in addition to the current value.
46Table Al.




P_i .77 (.02) .75 (.03) .75 (.03)
.24 (.03) .26 (.03) .26 (.03)
P_3
-.06(.02) -.08 (.02) -.07(.02)
a_I .08 (.02) .12 (.03) .11 (.03)
a2 -.17(.04) -.14 (.04) -.14 (.04)
a3 .07(.03) .04 (.03) .04 (.03)
p1 .20 10 (.13 10).19 103C13 l0)
Squared .11 I0 (.22 l0).13 i0(.24 10)
P2 Cubed -.37 i06 (.56 i0_6) -.42 i06(.57 10.6)
P1 Fourth power .50 (.37 i0).54 i0(.38 i0)
R1 Squared -.14 l0 (.18 10) -.10 10(.08 10)
RI Cubed .19 io6(.081o6).16 1o6(.os 1o6)
K1 Fourth power -.07 l0 (.02 i0) -.07 10(.02 1C9)
K1 Squared p_i .01 106 (.07 i06).01 106(.07 106)
P1 Squared •K1 .55 io6 (.17102) .54 1o6(.17 1o6)
Industry dummies no no yes
Standard error 16.8 16.5 16.6
a-squared .970 .97 .97
The dependent variable is the number of patent applications taken out by
the firm during the year which were later granted.
Allequationsinclude year dummies. In column (3), twenty industry
dummies (at roughly the two and one halfdigit level) were included in
theregression.
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